Replies to post #251683 on Biotech Values

[oc631]

PFE/MRNA—1Q24 COVID-vaccine worldwide_market_share—>68/32 in favor of PFE.

More specifically worldwide mRNA COVID vaccine market share. I don't want you further upsetting NVAX investors. Did PFE breakdown their U.S. mRNA vaccine market share?